Logo image
New search Researchers Research units
Sign in
In persons at intermediate risk for CVD, polypills reduce a composite of CV events at 5 y
Journal article   Peer reviewed

In persons at intermediate risk for CVD, polypills reduce a composite of CV events at 5 y

Krysta Brown and Anthony A Donato
Annals of internal medicine, v 175(1), pp JC2-JC3
Jan 2022
PMID: 34978850

Abstract

Aspirin - therapeutic use Cardiovascular Diseases - prevention & control Drug Combinations Humans Primary Prevention

Metrics

1 Record Views

Details

Logo image